Webinar: Flexible & Scalable Genetic Screens for Novel Therapeutic Target Discovery: An Overview of Noteworthy Case Studies

Date: Thursday, January 20, 2022

Time: 10:00 am - 11:00 am USA Pacific Time (PT); 

1:00 pm - 2:00 pm USA Eastern Time (ET); 19:00 h - 20:00 h CEST


Paul Diehl, Ph.D., Chief Operating Officer, Cellecta Inc. 


Measurements of changes in gene activation and expression provide a basis to understand genetic changes causing biological responses. Cell-to-cell gene disruption induced by CRISPR and other gene-perturbation technologies help tease out the drivers of these responses. Adaptations of these two screening approaches can be used to discover the genetic drivers responsible for phenotypic variabilities such as drug sensitivities and disease variation across tissue microenvironments, and between single cells. An overview of recent publications illustrating successful use of these methods will be presented.

A brief overview of Cellecta technologies will precede the presentation

Webinar highlights

Get an overview of recent peer-reviewed publications demonstrating how functional CRISPR screening and other related methods have been used to identify:

  • genes modulating drug response
  • genes responsible for drug resistance
  • possible mechanisms of action of drugs
Register Now
Please email info@cellecta.com with any comments.

Also in Events, Conferences, Meetings

FOCIS 2024 Annual Meeting

June 18-21, 2024
Read More
AIRR Community Meeting

June 3-6, 2024
Read More
Immunology2024 Conference

May 3-7, 2024
Read More